A. Weller et L. Dubson, A CCKA-RECEPTOR ANTAGONIST ADMINISTERED TO THE NEONATE ALTERS MOTHER-INFANT INTERACTIONS IN THE RAT, Pharmacology, biochemistry and behavior, 59(4), 1998, pp. 843-851
The importance of the infant's cholecystokinin (CCK) system for elicit
ing optimal maternal care was examined in 6-9-day-old Sprague-Dawley r
ats. After administration of either vehicle, CCK-8 (1 or 8 mu g/kg) or
devazepide (1 mg/kg; a selective CCKA receptor antagonist), pups were
either individually isolated (Experiment 1) or individually reunited
with their dam (Experiment 2) and the rats' behavior was observed. Whe
n isolated, pups that received devazepide displayed significantly more
head-lifting and wall-climbing attempts than vehicle-treated controls
, suggesting that endogenous CCK dampens activity. Devazepide-treated
rats were found more frequently in proximity with their mothers when r
eunited with them, and they emitted more ultrasonic vocalizations comp
ared to vehicle controls. Pups treated with 1 mu g/kg CCK received les
s body licking than vehicle controls. In addition, dams hovered and cr
ouched over devazepide-treated pups more than over pups treated with 1
mu g/kg CCK. The results suggest that endogenous CCK has a calming, q
uieting effect in the neonatal pup and that this, in turn, results in
less infant-mother attractivity and reduced levels of maternal care. (
C) 1998 Elsevier Science Inc.